Hosted on MSN

AstraZeneca’s Phase I Study on Saruparib: A Potential Game-Changer in Cancer Treatment

AstraZeneca ((AZN)), AstraZeneca plc ((GB:AZN)), AstraZeneca ((DE:ZEGA)), AstraZeneca plc US ((AZNCF)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% ...

AstraZeneca PLC (AZN) Stock Falls as FDA Panel Votes Against New Cancer Drug

AstraZeneca PLC (NYSE:AZN) is among the Best Biotech Stocks. On May 1, CNBC reported that an FDA advisory panel voted 6-3 ...
Hosted on MSN

AstraZeneca’s Promising CAR T-Cell Therapy Study: Key Insights for Investors

AstraZeneca ((AZN)), AstraZeneca plc ((GB:AZN)), AstraZeneca ((DE:ZEGA)), AstraZeneca plc US ((AZNCF)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% ...

5 Best Cancer Stocks to Buy for the Long Term

TheFly reported on May 6 that CDT Equity announced that AZD5904, a selective inhibitor of human myeloperoxidase originally ...
KXAN

Study shows AstraZeneca pill can cut deaths from a type of lung cancer in half

AUSTIN (KXAN) – An AstraZeneca drug has been shown to reduce the risk of death in some lung cancer patients by more than half, according to the research. Results from a three-year-long clinical trial ...
Yahoo

AstraZeneca vaccine booster works against Omicron, Oxford lab study finds

(Reuters) - A three-dose course of AstraZeneca's COVID-19 vaccine is effective against the rapidly-spreading Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from ...